Danaher (DHR) Hits New 12-Month High at $95.17
Shares of Danaher Co. (NYSE:DHR) reached a new 52-week high during mid-day trading on Monday . The company traded as high as $95.17 and last traded at $94.71, with a volume of 1880600 shares changing hands. The stock had previously closed at $94.12.
DHR has been the topic of a number of recent research reports. Citigroup lifted their target price on Danaher to $107.00 and gave the company a “buy” rating in a research report on Friday, December 15th. Goldman Sachs Group reissued a “neutral” rating and set a $83.00 price target on shares of Danaher in a research report on Tuesday, September 26th. Royal Bank of Canada reissued a “hold” rating and set a $96.00 price target on shares of Danaher in a research report on Thursday, January 4th. Credit Suisse Group boosted their price target on Danaher from $93.00 to $96.00 and gave the stock an “outperform” rating in a research report on Friday, October 20th. Finally, Robert W. Baird reissued a “buy” rating and set a $99.00 price target on shares of Danaher in a research report on Friday, December 15th. One analyst has rated the stock with a sell rating, six have issued a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Danaher currently has a consensus rating of “Buy” and an average target price of $94.91.
The stock has a market capitalization of $68,590.00, a PE ratio of 29.35, a price-to-earnings-growth ratio of 2.07 and a beta of 1.03. The company has a quick ratio of 1.00, a current ratio of 1.43 and a debt-to-equity ratio of 0.42.
The company also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Stockholders of record on Friday, December 29th will be given a $0.14 dividend. This represents a $0.56 annualized dividend and a dividend yield of 0.57%. The ex-dividend date is Thursday, December 28th. Danaher’s payout ratio is 16.67%.
In other news, SVP Daniel Raskas sold 37,870 shares of the company’s stock in a transaction that occurred on Thursday, November 16th. The stock was sold at an average price of $93.33, for a total value of $3,534,407.10. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Donald J. Ehrlich sold 10,578 shares of the company’s stock in a transaction that occurred on Tuesday, October 24th. The shares were sold at an average price of $90.82, for a total value of $960,693.96. Following the completion of the transaction, the director now directly owns 104,621 shares in the company, valued at approximately $9,501,679.22. The disclosure for this sale can be found here. Insiders sold 273,810 shares of company stock worth $25,218,813 in the last ninety days. 12.20% of the stock is owned by company insiders.
Institutional investors have recently bought and sold shares of the company. Progressive Investment Management Corp boosted its stake in shares of Danaher by 5.9% in the fourth quarter. Progressive Investment Management Corp now owns 37,108 shares of the conglomerate’s stock valued at $3,444,000 after buying an additional 2,074 shares during the period. QUANTRES ASSET MANAGEMENT Ltd boosted its stake in shares of Danaher by 21.4% in the fourth quarter. QUANTRES ASSET MANAGEMENT Ltd now owns 6,800 shares of the conglomerate’s stock valued at $631,000 after buying an additional 1,200 shares during the period. Neville Rodie & Shaw Inc. boosted its stake in shares of Danaher by 1.3% in the fourth quarter. Neville Rodie & Shaw Inc. now owns 51,562 shares of the conglomerate’s stock valued at $4,786,000 after buying an additional 650 shares during the period. Prudential Financial Inc. boosted its stake in shares of Danaher by 5.2% in the third quarter. Prudential Financial Inc. now owns 2,628,584 shares of the conglomerate’s stock valued at $225,480,000 after buying an additional 130,621 shares during the period. Finally, Atlantic Trust Group LLC boosted its stake in shares of Danaher by 7.9% in the third quarter. Atlantic Trust Group LLC now owns 2,223,836 shares of the conglomerate’s stock valued at $190,762,000 after buying an additional 163,306 shares during the period. 76.05% of the stock is currently owned by institutional investors.
TRADEMARK VIOLATION NOTICE: This article was first published by Watch List News and is owned by of Watch List News. If you are reading this article on another website, it was stolen and reposted in violation of United States & international copyright legislation. The correct version of this article can be read at https://www.watchlistnews.com/danaher-dhr-hits-new-12-month-high-at-95-17/1800826.html.
Danaher Company Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.